Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas

Cancer

Volumn 88, Issue 10, 2000, Pages 2201-2209

  Ohashi, Kenichi ^a   Nemoto, Tetsuo ^a   Nakamura, Kyoichi ^a   Nemori, Ryoichi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b FUJIFILM CORPORATION   (Japan)

Author keywords

Esophagus; Extracellular matrix; Invasion; Matrix metalloproteinases; Metastasis; Pathology; Squamous cell carcinomas

Indexed keywords

GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE;

ARTICLE; CANCER INVASION; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 15; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; SURVIVAL RATE;

EID: 0034657041     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000515)88:10<2201::AID-CNCR2>3.0.CO;2-N     Document Type: Article

References (55)

1. Sugimachi K, Ohno S, Matsuda H, Mori M, Kuwano H. Lugol-combined endoscopic detection of minute malignant lesions of the thoracic esophagus. Ann Surg 1988;208:179-83.
2. Ota H, Takagi K, Ohashi I, Tamura S, Kuno K, Kajitani T, et al. Studies on 1000 cases of early gastric carcinoma [in Japanese with English abstract]. Jpn J Gastroenterol 1981;14: 1399-1408.
3. Endo M, Yoshino K, Kawano T, Yano K. Clinical evaluation of mucosal cancer of the esophagus: analysis of 1584 cases of superficial esophageal cancer resected in Japan. In: Nabeya K, Hanaoka T, Nogami H, editors. Recent advances in disease of the esophagus. New York: Springer, 1993:540-5.
4. Kato H, Tachimori Y, Watanabe H. Superficial esophageal carcinoma: will early detection help? Cancer 1990;66:2319-33.
5. Nabeya K. Early carcinoma of the esophagus. In: Nabeya K, Hanaoka T, Nogami H. editors. Recent advances in disease of the esophagus. New York: Springer, 1993:374-80.
6. Nishimaki T, Tanaka O, Suzuki T, Aizawa K, Watanabe H, Muto T. Tumor spread in superficial esophageal cancer: histopathologic basis for rational surgical treatment. World J Surg 1993;17:766-72.
7. Peracchia A, Ruol A, Bonavina L, Bardini R, Segalin A, Castoro C. Early squamous cell carcinoma of the esophagus: diagnosis and management. Dig Surg 1989;6:109-13.
8. Ohashi K, Nemoto T, Eishi Y, Matsuno A, Nakamura K, Hirokawa K. Proliferative activity and p53 protein accumulation correlate with early invasive trend, and apoptosis correlates with differentiation grade in oesophageal squamous cell carcinomas. Virchows Arch 1997;430:107-15.
9. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-60.
10. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
11. Stetler-Stevenson WG, Aznavoorian S, Liotta IA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-73.
12. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994;370:61-5.
13. Ohashi K, Kawai R, Hara M, Okada Y, Tachibana S, Ogura Y. Increased matrix metalloproteinases as possible cause of osseoarticular tissue destruction in long-term haemodialysis and beta2-microglobulin amyloidosis. Virchows Arch 1996;428:37-46.
14. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T, et al. Production of matrix metalloproteinase-3 related to malignant behavior of esophageal carcinoma. Cancer 1992;70:2747-53.
15. Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park CS, et al. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997;79:139-44.
16. McDonnell S, Navre M, Coffey RJ Jr., Matrisian LM. Expression and localization of the matrix metalloproteinase pump-1(MMP-7) in human gastric and colon carcinomas. Mol Carcinogenesis 1991;4:527-33.
17. Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT. Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 1991;117:144-50.
18. Honda M, Mori M, Ueo H, Sugimachi K, Akiyoshi T. Matrix metalloproteinase-7 expression in gastric carcinoma. Gut 1996;39:444-8.
19. Mori M, Bernard GF, Mimori K, Ueo H, Akiyoshi T, Sugimachi K. Over-expression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer 1995;75:1516-9.
20. Ashida K, Nakatsukasa H, Higashi T, Ohguchi S, Hino N, Nouso K, et al. Cellular distribution of 92-kd type IV collagenase/gelatinase B in human hepatocellular carcinoma. Am J Pathol 1996;149:1803-11.
21. Nomura H, Sato H, Seiki M, Mai M, Okada Y. Expression of membrane type matrix metalloproteinase in human gastric carcinomas. Cancer Res 1995;55:3263-6.
22. Polette M, Nawrocki B, Gilles C, Sato H, Seiki M, Tournier JM, et al. MT-MMP expression and localization in human lung and breast carcinoma. Virchows Arch 1996;428:29-35.
23. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, et al. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinases in human papillary thyroid carcinomas. Cancer Res 1999;59:467-73.
24. Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, et al. Expression and tissue localization of membrane-type 1,2, and 3 matrix metalloproteinases in human astrocytic tumors. Am J Pathol 1999;154:417-28.
25. Kato H, Tachimori Y, Watanabe H, Iizuka T. Evaluation of the new (1987) TNM classification for thoracic esophageal tumors. Int J Cancer 1993;53:220-3.
26. Skinner DB, Little AG, Ferguson MK, Soriano A, Staszak VM. Selection of operation for esophageal cancer based on staging. Ann Surg 1986;204:391-401.
27. Otani Y, Okazaki I, Arai M, Kameyama K, Wada N, Maruyama K, et al. Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers. J Gastroenterol 1994;29:391-7.
28. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumors. Int J Cancer 1991;49:666-72.
29. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 1996;69:9-16.
30. Auto-Harmainen H, Karttunen T, Hurskainen T, Höyhtyä M, Kauppila A, Tryggvason K. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest 1993;69:312-21.
31. David L, Nesland JM, Holm R, Sobrinho-Simões M. Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. Cancer 1994;85:518-27.
32. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67: 1126-31.
33. Poulson R, Pignatelli M, Stetler-Stevenson WG, Liotta LA, Wright PA, Jeffery RE, et al. Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am J Pathol 1992;141:389-96.
34. Pyke C, Ralfkiaer E, Tryggvason K, Danø K. Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359-65.
35. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq J-P, et al. Stromlysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Nat Acad Sci USA 1993;90:1843-7.
36. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells: activation of the precursor, interaction with other matrix metalloproteinase and enzymic properties. J Biol Chem 1995;270:6691-7.
37. Sires UI, Griffin GL, Broekelmann TJ, Mecham RP, Murphy G, Chung AE, et al. Degradation of entactin by matrix metalloproteinases: susceptibility of matrilysin and identification of cleavage sites. J Biol Chem 1993;268:2069-74.
38. Yamashita K, Azumano I, Mai M, Okada Y. Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas: implications for vessel invasion and metastasis. Int J Cancer 1998;79:187-94.
39. Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K, Yachi A. Expression of MMP-7 (PUMP-1) mRNA in human colorectal cancers. Int J Cancer 1993;54:614-8.
40. Visscher DW, Höyhtyä M, Ottosen SK, Liang C-M, Sarkar FH, Crisman JD, et al. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 1994; 59:339-44.
41. Canete-Soler R, Litsky L, Lubensky I, Muschel RJ. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J Pathol 1994;144:518-27.
42. Nagase H, Okada Y. Proteinases and matrix degradation. In: Kelly WN, Harris ED Jr., Rubby S, Sledge CB, editors. Textbook of rheumatology. 5th edition. Philadelphia: W. B. Saunders, 1997:323-41.
43. Strongin AY, Marmer BL, Grant GA, Goldberg GI. Plasma membrane-dependent activation of 72 kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1993;268:14033-9.
44. Strogin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem 1995;270:5331-8.
45. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts: purification and activation of the precursor and enzymic properties. Eur J Biochem 1990; 194:721-30.
46. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y, et al. Membrane-type matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997;272:2446-51.
47. Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 1996;56:384-92.
48. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T. A one-step sandwich immunoassay for human matrix metalloproteinase 1 (interstitial collagenase). Clin Chim Acta 1993;219:1-14.
49. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103.
50. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin 1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72.
51. Ohuchi E, Azumano I, Yoshida S, Iwata K, Okada Y. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies. Clin Chim Acta 1996;244:181-98.
52. Fujimoto N, Mouri N, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92-kDa gelatinase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
53. Nakazawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T, et al. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 1994;81:69-77.
54. Fujimoto N, Zang J, Iwata K, Shinya T, Okada Y, Hayakawa T. A one step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinase-2 using monoclonal antibodies. Clin Chim Acta 1993;220:31-45.
55. Ueno H, Nakamura H, Inoue M, Imai K, Nogichi M, Sato H, et al. Expression and tissue localization of membrane type 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 1997;57:2055-60.